Cite

HARVARD Citation

    Gleeson, M. et al. (2018). CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. Lancet. 5 (5), pp. e190-e200. [Online]. 
  
Back to record